OCT4 and SOX2 Specific Cytotoxic T Cells Exhibit Not Only Good Efficiency but Also Synergize PD-1 Inhibitor (Nivolumab) in Treating Breast Cancer Stem-Like Cells and Drug-Resistant Breast Cancer Mice

PURPOSE: This study aimed to investigate the effect of OCT4&SOX2 specific cytotoxic T lymphocytes (CTLs) plus programmed cell death protein-1 (PD-1) inhibitor (nivolumab) on treating breast cancer stem-like cells (BCSCs) in vitro and drug-resistance breast cancer (DRBC) mice in vivo. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Wei, Chang, Liang, Li, Wenqiang, Liu, Yanan, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987438/
https://www.ncbi.nlm.nih.gov/pubmed/35402219
http://dx.doi.org/10.3389/fonc.2022.781093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987438/
https://www.ncbi.nlm.nih.gov/pubmed/35402219
http://dx.doi.org/10.3389/fonc.2022.781093

Ejemplares similares